Publication: 2779

Publication: 2779

An Analysis of Maintenance Therapy and Post-Midostaurin Outcomes in the International Prospective Randomized, Placebo-Controlled, Double-Blind Trial (CALGB 10603/RATIFY [Alliance]) for Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with FLT3 Mutations

URL

URL

Google Scholar

Citation:: Blood vol 130 (Suppl 1) 145

Meeting Instance:: ASH 2017
Year:: 2017
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 3367

Program:: OGC
Primary Committee:: Leukemia
Sec. Committees:

Pharmas:: Novartis
Grants:: U10CA180821, U10CA180882, U10CA180791, U10CA180820, U10CA180888, U24CA196171

Corr. Author:
Authors:: Richard A. Larson Sumithra Mandrekar Ben L Sanford Kristine Laumann Susan Geyer Clara D. Bloomfield Christian Thiede T W Prior Konstanze Dohner Guido Marcucci Francesco Lo-Coco Rebecca B. Klisovic Andrew Wei Jorge Sierra Miguel A. Sanz Joseph M. Brandwein Theo de Witte Dietger Niederwieser Frederick R. Appelbaum Bruno C. Medeiros Martin S Tallman Jurgen Krauter *Richard F. Schlenk Arnold Ganser Hubert Serve Gerhard Ehninger Sergio Amadori Hartmut Dohner Richard M. Stone

Networks:: CA043, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-OH007, PA075

Study: CALGB-10603
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: